Mechanistically, our data showed that resistant cancer cells had higher levels of NF-κB activity compared to their parental, sensitive cancer cells, while NF-κB is reported to be constitutively activated in a wide variety of tumor types including lung and breast cancers compared with their respective normal tissues or cells (33). The gene discussed is NFKB1; the disease is neoplasm.